Article info
PDFBasic Science
Targeting Foxm1 Improves Cytotoxicity of Paclitaxel and Cisplatinum in Platinum-Resistant Ovarian Cancer
- Address correspondence and reprint requests to Nelson N. H. Teng, MD, PhD, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology Stanford Cancer Institute Stanford University, 300 Pasteur Dr, HH333 Stanford, CA 94305. E-mail: teng@stanford.edu.
Citation
Targeting Foxm1 Improves Cytotoxicity of Paclitaxel and Cisplatinum in Platinum-Resistant Ovarian Cancer
Publication history
- Received January 27, 2017
- First published June 1, 2017.
Online issue publication
February 26, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright © 2017 by IGCS and ESGO